Leaflet IMOGAM RAGE 150UI / ml solution for injection


Indicated for: immunosuppression

Route of administration: injectable

Substance: human anti-rabies immunoglobulin (immunoglobulin)

ATC: J06BB05 (Antiinfectives for systemic use | Immunoglobulins | Specific immunoglobulins)

Human rabies immunoglobulin is a plasma-derived product used to prevent rabies in individuals exposed to the rabies virus, usually through bites from infected animals. It provides passive immunity by supplying specific antibodies against the rabies virus.

The medication is administered via intramuscular injection, as directed by a doctor, and is used in combination with the rabies vaccine.

Side effects may include pain at the injection site, fever, allergic reactions, or, in rare cases, anaphylactic reactions.

Patients should inform their doctor about any known allergies or other medications they are taking. Pregnant or breastfeeding women should consult a specialist before use.

General data about IMOGAM RAGE 150UI / ml

  • Substance: human anti-rabies immunoglobulin
  • Date of last drug list: 01-10-2022
  • Commercial code: W67878001
  • Concentration: 150UI / ml
  • Pharmaceutical form: solution for injection
  • Quantity: 1
  • Product type: generic
  • Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

  • Manufacturer: SANOFI PASTEUR - FRANTA
  • Holder: ALLIANCE HEALTHCARE ROMANIA - ROMANIA
  • Number: 629/2021/01
  • Shelf life: 3 years